tuberculosis, and tetanic toxoid. Analysis of the specific immune response to mycobacterial antigens in comparison to the NS culture revealed an increase in spot-forming cells both in RR and RR/HIV when cells were stimulated with ML [Fig. 2a,b; RR NS = 135 (30–260) versus ML = 830 (50–5380); P < 0·01; RR/HIV NS = 202·5 (40·0–2560) versus ML = 2260 (50·0–7380); P < 0·05]. The ML p38 peptide
did not modulate the frequency of IFN-γ-producing cells after 48 hr of culture in the PBMCs of the different groups tested. ML peptide p69, which induces a T CD8 response, increased the www.selleckchem.com/products/AZD2281(Olaparib).html frequency of IFN-γ-producing cells in the PBMCs of RR patients when compared with NS cells [Fig. 2a,b; RR NS = 140 (50–250) versus PD0332991 purchase p69 = 830 (390–1000); P < 0·05]. However, no significant differences were observed between the PBMCs of RR/HIV stimulated or not with p69 (Fig. 2a,b). In addition, an increase in IFN-γ production in both RR and RR/HIV cells stimulated in vitro with p69 was also observed in contrast to cells in the HC group under the same conditions [Fig. 2b; HC 370 (70–650) versus RR/HIV 830 (250–1960); P < 0·05]. Although M. tuberculosis stimulation induced spots in both RR and RR/HIV cells, there
were no significant differences when compared with unstimulated cells or the HC group. Tetanus toxoid induced an increase in IFN-γ production only in the HC group when compared with NS cells (Fig 2a,b). As expected, PHA stimulation induced a greater number of spots in the HC, RR and RR/HIV groups when compared with the NS cells (Fig. 2a,b). HIV infection induces OSBPL9 significant immunological impairment, resulting in the increased expression of activation markers such as CD38 and HLA-DR in CD8+ T cells. This increased expression has been associated with particular clinical outcomes.[24] The next step was to evaluate whether ML stimulation modulates the activation of the immune system in RR/HIV co-infected patients. For this purpose, cellular activation parameters were investigated by analysing the surface expression
markers CD25, CD69 and CD38 in both CD4 and CD8 T cells in the PBMC cell culture after stimulation with irradiated ML for 24 hr. As observed in Fig. 3(a), ML increased CD4+ CD69+ T-cell frequencies in the HC and RR groups but not in the RR/HIV patients that presented a greater percentage of CD4+ CD69+ cells in the NS cell culture regardless of ML stimulus [Fig. 3a,b; HC NS = 2·78 (1·57–5·42) versus ML = 9·33 (4·97–17·43), P < 0·01; RR NS = 2·27 (0·57–8·72) versus ML = 10·39 (7·27–18·87), P < 0·01]. Although ML did not affect the expression of CD4+ T-cell activation markers in RR/HIV patients, an increase in CD8+ CD69+ T-cell frequencies in ML-stimulated cells was observed in this group compared with the NS cells [Fig. 4a,b; NS = 13·90 (5·16–22·80) versus ML = 44·49 (21·69–56·90), P < 0·05].